Literature DB >> 18969168

Study of interactions between DNA-ethidium bromide (EB) and DNA-acridine orange (AO), in solution, using hanging mercury drop electrode (HMDE).

I Ch Gherghi1, S T Girousi, A N Voulgaropoulos, R Tzimou-Tsitouridou.   

Abstract

The interaction of ethidium bromide (EB) and acridine orange (AO) with double stranded (ds), thermally denatured (ss) and supercoiled (sc) DNA, in solution, was studied by alternating current voltammetry (AC voltammetry) at the hanging mercury drop electrode (HMDE) in 0.3 M NaCl+50 mM sodium phosphate buffer (pH 8.5). Their interaction with DNA is shown to be time dependent and completely different. The changes at peak 2 (peak at -1.20 V) of dsDNA form and the appearance of peak 3 (peak at -1.42 V) in scDNA form are presented as criteria declaring the different mechanism of interaction of EB and AO with DNA. Additionally, the appearance of a new peak at around -0.44 V as a result of DNA and AO interaction, differentiates the studied behaviors. The comparison of the electrochemical behaviors of these compounds highlights the differences in the mechanism of interaction.

Entities:  

Year:  2003        PMID: 18969168     DOI: 10.1016/S0039-9140(03)00238-8

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  11 in total

1.  Novel association between apoptotic sperm biomarkers with seminal biochemical parameters and acetylcholinesterase activity in patients with teratozoospermia.

Authors:  Oumaima Ammar; Meriem Mehdi; Oumayma Tekeya; Fadoua Neffati; Zohra Haouas
Journal:  J Assist Reprod Genet       Date:  2019-09-11       Impact factor: 3.412

2.  Cannabinoids pharmacological effects are beyond the palliative effects: CB2 cannabinoid receptor agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29).

Authors:  Aylar Alenabi; Hassan Malekinejad
Journal:  Mol Cell Biochem       Date:  2021-04-22       Impact factor: 3.396

3.  Anticancer potential of yohimbine in drug-resistant oral cancer KB-ChR-8-5 cells.

Authors:  Nasimudeen R Jabir; Mohd Shahnawaz Khan; Nouf Omar Alafaleq; Huma Naz; Bakrudeen Ali Ahmed
Journal:  Mol Biol Rep       Date:  2022-08-16       Impact factor: 2.742

4.  Lupeol synergizes with doxorubicin to induce anti-proliferative and apoptotic effects on breast cancer cells.

Authors:  Faezeh Malekinejad; Fatemeh Kheradmand; Mohammad Hassan Khadem-Ansari; Hassan Malekinejad
Journal:  Daru       Date:  2022-02-03       Impact factor: 4.088

5.  Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry.

Authors:  Kuan Liu; Peng-cheng Liu; Run Liu; Xing Wu
Journal:  Med Sci Monit Basic Res       Date:  2015-02-09

6.  Niclosamide loaded biodegradable chitosan nanocargoes: an in vitro study for potential application in cancer therapy.

Authors:  Saba Naqvi; Shanid Mohiyuddin; P Gopinath
Journal:  R Soc Open Sci       Date:  2017-11-08       Impact factor: 2.963

7.  Silibinin Triggers the Mitochondrial Pathway of Apoptosis in Human Oral Squamous Carcinoma Cells.

Authors:  Radhika Murali Iyangar; Ezhilarasan Devaraj
Journal:  Asian Pac J Cancer Prev       Date:  2020-07-01

8.  Zinc oxide nanoparticles from Cassia auriculata flowers showed the potent antimicrobial and in vitro anticancer activity against the osteosarcoma MG-63 cells.

Authors:  Vidya Devanathadesikan Seshadri
Journal:  Saudi J Biol Sci       Date:  2021-04-12       Impact factor: 4.219

9.  Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway.

Authors:  Suresh Mickymaray; Faiz Abdulaziz Alfaiz; Anand Paramasivam; Vishnu Priya Veeraraghavan; Nanthini Devi Periadurai; Krishna Mohan Surapaneni; Guangfeng Niu
Journal:  Saudi J Biol Sci       Date:  2021-05-08       Impact factor: 4.219

10.  Anticancer Activity of Anthopleura anjunae Oligopeptides in Prostate Cancer DU-145 Cells.

Authors:  Zong-Ze Wu; Guo-Fang Ding; Fang-Fang Huang; Zui-Su Yang; Fang-Miao Yu; Yu-Ping Tang; Ying-Lu Jia; Yuan-Yuan Zheng; Rui Chen
Journal:  Mar Drugs       Date:  2018-04-12       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.